Decitabine (Dacogen) Injection – Treatment for Blood Cancer
Decitabine or Dacogen Injection is used to treat acute myeloid leukemia, a kind of blood cancer (AML). It is also used to treat myelodysplastic syndrome patients (MDS). It may be used to treat other conditions if the doctor determines it is necessary.
Dacogen Injection is used to treat myelodysplastic syndrome, a set of disorders in which the bone marrow generates defective blood cells while not producing enough healthy blood cells. Dacogen Injection destroys or slows the growth of cancer cells while also preventing their replication. It is a highly effective but extremely toxic medication, and you should evaluate the risks and benefits with your doctor.
Dacogen injection is also used in combination with other medications as part of chemotherapy. It is injected into a vein under the guidance of a doctor.
USES OF DECITABINE (DACOGEN) INJECTION
- Blood cancer
- Myelodysplastic syndrome
WORKS OF DECITABINE (DACOGEN) INJECTION
Dacogen Injection disrupts the growth of cancer cells’ DNA and RNA by replacing their building blocks. It inhibits the growth and multiplication of cancer cells.
SIDE EFFECTS OF DECITABINE (DACOGEN) INJECTION
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Lung infection
- Decreased white blood cell count (neutrophils)
- Anemia (low number of red blood cells)
- Low blood platelets
WARNING & PRECAUTIONS
Dacogen Injection may have negative effects that impair your ability to drive.
After using Dacogen Injection, you may feel sleepy or weak, which may impair your ability to drive.
In patients with kidney problems, Dacogen Injection should be taken with caution. Dacogen injection dosage may need to be adjusted. Please consult your physician.
There is little data on the usage of Dacogen Injection in patients with liver disease. Please consult your physician.
Dacogen Injection is not safe to use during pregnancy because there is clear evidence that it poses harm to the growing infant. However, if the benefits outweigh the risks, the doctor may rarely prescribe it in life-threatening situations. Please consult your physician.
Fedelty Health Care is a Decitabine third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.